Wiscon Pharmaceuticals Private Limited, a active private limited company, was established on 22 February 2007 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74900MH2007PTC286130. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Employing 33 professional, Its leadership includes Rakeshkumar Dilipkumar Patel (Director), Kartik Gautam Parikh (Managing Director). Past directors included Sibeswar Parial, Bharat Nanubhai Patel. It holds ₹3.55 Cr open charges and ₹11.25 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-19, Ground Floor,Ansa Industrial Estate, Saki Vihar Road, Kurla, Mumbai, Maharashtra, 400072.
U74900MH2007PTC286130
286130
22 February 2007
₹2.50 M
₹1.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Wiscon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakeshkumar Dilipkumar Patel | Director | 18 Jun 2015 | Current |
| Kartik Gautam Parikh | Managing Director | 22 Feb 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Oct 2008 | Past |
| Pramod Abcsdd | Director | 18 Jun 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Wiscon Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 19.16% decrease. The company also saw a slight decrease in profitability, with a 4.6% decrease in profit. The company's net worth Soared by an impressive increase of 47.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Wiscon Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹35,450,000.00
₹112,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 May 2023 | Yes Bank Limited | ₹3.50 Cr | Open |
| 14 Feb 2022 | Others | ₹0.45 M | Open |
| 16 Jan 2008 | Bank Of Baroda | ₹11.25 Cr | Satisfied |
Explore comprehensive loan charge details -
Wiscon Pharmaceuticals has a workforce of 33 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Wiscon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wiscon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Wiscon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Wiscon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity A charge registered on 16 Jan 2008 via Charge ID 10089816 with Bank Of Baroda was fully satisfied on 11 Jul 2023. was completed.
A charge with Yes Bank Limited amounted to Rs. 35.00 M with Charge ID 100759598 was registered on 11 May 2023. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 0.45 M with Charge ID 100535167 was registered on 14 Feb 2022. was documented.
Progress on Rakeshkumar Dilipkumar Patel was appointed as a Director was appointed as a Director on 18 Jun 2015 & has been associated with this company since 10 years 5 months . was documented.
The CIN of Wiscon Pharmaceuticals Private Limited is U74900MH2007PTC286130.
Wiscon Pharmaceuticals Private Limited is headquartered at B-19, Ground Floor,Ansa Industrial Estate, Saki Vihar Road, Kurla, Mumbai, Maharashtra, 400072.
Wiscon Pharmaceuticals Private Limited was incorporated on 22 February 2007.
The current directors of Wiscon Pharmaceuticals Private Limited are
The primary industry of Wiscon Pharmaceuticals Private Limited is Trade.
Wiscon Pharmaceuticals Private Limited is unlisted.
The authorized capital of Wiscon Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹1.50 M.
The compliance status of Wiscon Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX